Global Medicare · Specialist Fertility Pathways
Complex fertility decisions deserve specialist clarity.
Global Medicare helps patients access ovarian, endometrial and second-opinion pathways, coordinates international specialist care and connects each clinical question with its scientific and research context.
Global Medicare provides approved information, initial orientation and coordination. Diagnosis, interpretation of results, treatment decisions and research eligibility remain with the authorised medical and research teams.
Start here
Choose the access point that matches your role.
Patient orientation and professional enquiries follow different pathways. Choose your role to see the most relevant next steps.
Specialist pathways
Three ways to begin a specialist fertility review.
Each program starts with a different patient question, while medical interpretation and treatment decisions remain with the authorised clinical team.
Entering a Global Medicare Program does not confirm diagnosis, treatment suitability or participation in a research study.
How Global Medicare works
One coordinated journey. Four clearly separated stages.
Global Medicare helps organise the route between the patient’s first question and an appropriate specialist conversation.
Clinical care comes before any possible research consideration. Research does not select or assign treatment.
Begin with the general reason for seeking another fertility pathway or specialist review.
The authorised medical team reviews the individual clinical and reproductive context.
Diagnosis, treatment selection and recommendations remain within routine clinical care.
Possible research participation is considered separately by the authorised research team.
Science & Research
Understand the science. Explore the research.
Scientific background and specific research studies serve different purposes. Global Medicare gives each one its own clearly defined space.
Understand the context.
Explore ovarian reserve and response, endometrial development and the distinction between Standard-PRP and IAS.
Explore the questions.
Review the current prospective observational studies at IVF Baden-Baden and the evidence that informs their scientific rationale.
ExoRegenOvo and RegenEndo are observational, non-randomised studies. Their ongoing research should not be presented as proof of clinical superiority or guaranteed reproductive benefit.
Clinical & Research Centre
Baden-Baden
Specialist reproductive medicine and current REGEN-AR research at one centre.
IVF Baden-Baden is the clinical and research centre connected with the current ovarian and endometrial Global Medicare pathways.
Clinical care and research participation remain separate. Visiting IVF Baden-Baden does not automatically mean joining a research study.
Publications & Evidence
Evidence should clarify uncertainty — not hide it.
The scientific rationale behind the Global Medicare research programs draws on clinical studies, biological evidence and defined questions that still require further investigation.
Published findings are heterogeneous and must be interpreted according to study design, population and clinical context.
Randomised trials, clinical studies and cohorts have investigated PRP in ovarian and endometrial reproductive settings.
Platelet biology, growth factors and extracellular vesicles provide scientific background, but do not by themselves prove clinical benefit.
ExoRegenOvo and RegenEndo are building prospective evidence. Their outcomes are not presented as published study results at this stage.
Two access points
Built for patients and professionals.
Each audience receives a dedicated pathway while remaining connected to the same clinical, scientific and research framework.
Understand your next step.
Explore specialist programs, the patient journey, frequently asked questions and practical information about visiting IVF Baden-Baden.
Refer, collaborate and explore.
Access structured patient referral, clinical collaboration, scientific exchange and professional research pathways.
Clear boundaries
Trust begins with understanding who is responsible for what.
Global Medicare separates information, coordination, clinical care and research so that each part of the pathway remains transparent.
Individual findings require interpretation by authorised healthcare professionals.
Global Medicare does not prescribe medication or independently select treatment.
Research participation can only be assessed by the authorised medical and research teams.
Specialist evaluation or research participation cannot guarantee pregnancy or another clinical outcome.
Your next step
Start with the question you have today.
You do not need to identify the right treatment, specialist or research study before beginning. Start with your role and the reason for your enquiry, and continue through the appropriate pathway.
For general information or coordination, contact Global Medicare through the dedicated contact page.
